CAS: 1336960-13-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK2193874 REF: 54-BUP12717CAS: 1336960-13-4 | ≥98% | 375.00 €~2,157.00 € | Mon 28 Apr 25 |
 | GSK2193874 REF: TM-T5640CAS: 1336960-13-4 | 98.79% - ≥95% | 43.00 €~602.00 € | Tue 06 May 25 |
 | GSK 2193874 REF: 3D-LDC96013CAS: 1336960-13-4 | Min. 95% | 185.00 €~754.00 € | Wed 25 Jun 25 |
Ref: 54-BUP12717
| 1g | 2,157.00 € | ||
| 25mg | 375.00 € | ||
| 50mg | 605.00 € | ||
| 100mg | 882.00 € | ||
| 500mg | 1,604.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
GSK2193874
CAS:1336960-13-4
GSK2193874 was identified as a selective, orally active TRPV4 blocker.
Formula:
C37H38BrF3N4O
Purity:
98.79% - ≥95%
Color and Shape:
Solid
Molecular weight:
691.62
Ref: TM-T5640
| 1mg | 43.00 € | ||
| 2mg | 57.00 € | ||
| 5mg | 81.00 € | ||
| 10mg | 127.00 € | ||
| 25mg | 246.00 € | ||
| 50mg | 404.00 € | ||
| 100mg | 602.00 € | ||
| 1mL*10mM (DMSO) | 111.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
GSK 2193874
CAS:1336960-13-4
Please enquire for more information about GSK 2193874 including the price, delivery time and more …
Formula:
C37H38BrF3N4O
Purity:
Min. 95%
Molecular weight:
691.62 g/mol
Ref: 3D-LDC96013
| 5mg | 185.00 € | ||
| 10mg | 254.00 € | ||
| 25mg | 447.00 € | ||
| 50mg | 531.00 € | ||
| 100mg | 754.00 € |
Estimated delivery in United States, on Wednesday 25 Jun 2025
